What is Disaster Mental Health?
Disaster mental health refers to mental health services for victims, first responders, and medical personnel who experience disaster. Disaster can include a wide variety of sudden, catastrophic events that cause loss of life, such as an earthquake, a terrorist attack, or even a global pandemic.
What Conditions Are Associated With Disaster Mental Health?
Traumatic experiences during disaster can produce a variety of mental health conditions that last long after danger ends. Some of these may be related to neurological changes produced by long periods of “fight or flight.”
One of the most prominent conditions associated with disaster mental health is PTSD (Post-Traumatic Stress Disorder.) Once thought common only in military conflict, it is now understood PTSD can come from any intense experience of danger that provokes feelings of helplessness.

PTSD can have symptoms including flashbacks, memory loss (especially in relation to the traumatic event), anxiety, depression, difficulty sleeping, nightmares, and angry outbursts. The vast majority of PTSD sufferers are nonviolent and pose no threat to others.
Anxiety and depression are typical complications from any disaster. Both adults and children may feel guilty, believing they “should have done more.” Emotional flashbacks in which the sufferer re-experiences negative emotions without “seeing” or “hearing” the event, are common.
Disaster Mental Health Recovery and Lifestyle Changes
Disaster mental health treatment often includes a combination of medication and therapy. Medication focuses on reducing symptoms of anxiety and depression. Therapy can be in a group or one-on-one setting. Its primary goal is to help a sufferer process trauma.
One of the biggest challenges in disaster mental health care is the difficulty sufferers face verbalizing their experiences. Processing the emotions that come from trauma help reduce their effect on a person’s life. Novel approaches such as art therapy help many individuals express trauma in a way that helps. Techniques like journaling may also be used.
Disaster mental health patients need to identify psychological triggers in their environment. These triggers can cause them to re-experience the emotions or sensations of a past trauma. At first, recognizing and avoiding such triggers is advisable. With professional help, it’s possible to overcome the negative associations of triggers in a controlled environment.
Disaster Mental Health Research

Disaster mental health has been a prominent concern in psychology for decades. As researchers have uncovered effects of trauma on the brain, it has become clear profound neurological changes can occur during disaster even if one is not physically harmed.
Disaster mental health research focuses on two main areas: Reduction and treatment. Reduction aims to equip at-risk populations, like police and EMTs, with coping strategies to manage trauma. Treatment focuses on the neurobiology of trauma, creating better clinical resources for disaster mental health.
Why is Further Disaster Mental Health Research Necessary?
Millions of people all around the world are affected by mental health issues arising from disaster. The lessons of disaster mental health apply to everything from the COVID-19 outbreak to individual experiences of sexual assault or other criminal violence. With that in mind, all disaster mental health research has potential to help a broad spectrum of the population.
Disaster Mental Health Clinical Trials
This list contains all disaster mental health clinical trials on record at ClinicalTrials.gov. To feature a clinical trial on our site, contact us.
- A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsyon June 23, 2026 at 4:00 am
Conditions: Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS) Interventions: Other: NIO752; Drug: Placebo Sponsors: Novartis Pharmaceuticals Recruiting
- Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosison June 23, 2026 at 4:00 am
Conditions: Transthyretin Amyloidosis; ATTR-CM; ATTRv-PN; ATTR; ATTR-Mixed; hATTR Interventions: Drug: Treatment of transthyretin (ATTR) amyloidosis in observational study setting Sponsors: AstraZeneca; ICON plc Recruiting
- Virtual Menstrual Pain Approaches in Femaleson June 23, 2026 at 4:00 am
Conditions: Pain (Visceral, Somatic, or Neuropathic); Women of Reproductive Age; Mental Disorder; Digital Health; Acupressure; Traditional Exercise; Host-Gut Microbiota Interaction; Metabolomics Interventions: Behavioral: Virtual Auricular Acupressure; Behavioral: Virtual Baduanjin Qigong Exercise; Behavioral: Self Education Sponsors: Nanyang Technological University; Chengdu University of Traditional Chinese Medicine Recruiting
- Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Strokeon June 23, 2026 at 4:00 am
Conditions: Stroke; Brain Disease; Vascular Diseases; Cerebrovascular Disorder Sponsors: National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
- ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinicson June 23, 2026 at 4:00 am
Conditions: Parents; Children With Disabilities; Stress; Depression Interventions: Behavioral: ACT Together Sponsors: University of South Florida; American Occupational Therapy Foundation Recruiting
- NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)on June 23, 2026 at 4:00 am
Conditions: Major Depressive Disorder Interventions: Drug: NBI-1065845; Drug: Placebo Sponsors: Neurocrine Biosciences Recruiting
- A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)on June 23, 2026 at 4:00 am
Conditions: Bipolar Disorder Interventions: Drug: Brenipatide; Drug: Placebo Sponsors: Eli Lilly and Company Recruiting
- A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)on June 23, 2026 at 4:00 am
Conditions: Radiographic Axial Spondyloarthritis Interventions: Drug: Tulisokibart; Drug: Placebo Sponsors: Merck Sharp & Dohme LLC Recruiting
- eCardiacRehab - a Hybrid Patient-Centered eHealth Programmeon June 23, 2026 at 4:00 am
Conditions: Comorbidities and Coexisting Conditions; Ethics; Continuity of Patient Care; Older Adults (65 Years and Older); Cost-Benefit Analysis; Adherence, Medication; Secondary Prevention of Coronary Heart Disease; Health Literacy; eHealth Literacy; Mental Health; Cardiac Rehabilitation; Womens's Health; Coronary Artery Disease (CAD) Interventions: Other: eCardiacRehab Sponsors: Haukeland University Hospital; The Research Council of Norway; Helse Vest; Helse Fonna; Helse Møre og Romsdal HF; Helse Vest IKT; Western Norway University of Applied Sciences; Youwell; University of Bergen; Østfold University College; Norsk råd for digital etikk; Helse Førde HF; University of Amsterdam; Center for Research on Cardiac Disease in Women; Nasjonal kompetansetjeneste Trening som medisin; RELIS Vest; Norwegian Centre for E-health Research; Bergen Municipality; Sunnfjord Municipality; Sogndal Municipality; Masfjorden Municipality; The Norwegian Heart and Lung Patients Association (LHL); E-helse Vestland; Yale University; University of Sydney; University of Cambridge; University of Regina; University of Copenhagen; Linkoeping University; Voss Sykehus Recruiting
- Online Learning Module to Advance Research Related to People With Disabilitieson June 22, 2026 at 4:00 am
Conditions: Developmental Disability; Intellectual Disability; Disability Interventions: Other: eLearning module; Other: Control Sponsors: Albert Einstein College of Medicine; National Center for Advancing Translational Sciences (NCATS) Recruiting
- Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Diseaseon June 22, 2026 at 4:00 am
Conditions: Alzheimer Disease (AD); Mild Cognitive Impairment (MCI) Interventions: Device: Metronome Sponsors: Boston University Charles River Campus; National Institute on Aging (NIA) Recruiting
- Efficacy of Guselkumab in Treating Hailey Hailey Diseaseon June 22, 2026 at 4:00 am
Conditions: Hailey Hailey Disease Interventions: Drug: Guselkumab Sponsors: Yale University; Janssen Scientific Affairs, LLC Recruiting
Conclusion
With more people experiencing disaster, stigma around seeking disaster mental health treatment is beginning to fade. Disaster mental health clinical resources will depend on active clinical trials that uncover further information about the brain’s trauma response. Further medical research may help millions of people reclaim their sense of stability.
Sources
- https://www.phe.gov/Preparedness/planning/abc/Pages/disaster-behavioral.aspx
- https://www.medicalnewstoday.com/articles/325578
- https://www.rainn.org/articles/flashbacks
- https://emergency.cdc.gov/coping/index.asp
- https://www.mhanational.org/coping-disaster
- https://www.webmd.com/mental-health/what-are-treatments-for-posttraumatic-stress-disorder
- https://www.ptsd.va.gov/understand_tx/tx_basics.asp